Procaps Group S.A. (PROC)
NASDAQ: PROC · Real-Time Price · USD
2.510
+0.070 (2.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
Procaps Group Market Cap
Procaps Group has a market cap or net worth of $283.19 million as of December 20, 2024. Its market cap has increased by 0.40% in one year.
Market Cap
283.19M
Enterprise Value
555.55M
1-Year Change
0.40%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since December 9, 2019, Procaps Group's market cap has increased from $239.85M to $283.19M, an increase of 18.07%. That is a compound annual growth rate of 3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 283.19M | -38.33% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | 260.00M | 8.29% |
| Dec 31, 2019 | 240.09M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 291.70M |
| Aclaris Therapeutics | 291.00M |
| Aldeyra Therapeutics | 290.60M |
| Foghorn Therapeutics | 285.75M |
| Candel Therapeutics | 284.16M |
| aTyr Pharma | 281.21M |
| Accolade | 280.27M |
| C4 Therapeutics | 278.83M |